GlassScriptPhysician profile
James R Hess
NPI 1124092747
$10,862.24
in general payments reported to CMS, 2019-2025
53 companies · $2,330 in 2025
The $2,330 reported for 2025 was more than what 79% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $946 · 2021: $1,742 · 2022: $2,115 · 2023: $1,601 · 2024: $1,896 · 2025: $2,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,827.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,511.40 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,123.78 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $719.75 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $674.58 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $578.03 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Amneal Pharmaceuticals LLC | $543.60 | 2021-2025 | Unithroid |
| Insulet Corporation | $495.63 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $488.56 | 2021-2025 | |
| Amgen INC. | $460.34 | 2022-2025 | Tepezza, Evenity, Prolia |
| Harmony Biosciences LLC | $342.78 | 2020-2025 | |
| Abbvie INC. | $318.04 | 2021-2025 | |
| Antares Pharma, INC. | $284.07 | 2021-2025 | Xyosted |
| Corcept Therapeutics | $264.71 | 2021-2025 | Korlym |
| Merck Sharp & Dohme LLC | $236.46 | 2020-2022 | |
| Tandem Diabetes Care, INC. | $214.93 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $182.15 | 2021-2022 | |
| Horizon Therapeutics Plc | $169.76 | 2019-2023 | Tepezza |
| Recordati_rare_diseases_inc. | $147.11 | 2022-2025 | Isturisa, Signifor Lar |
| Medtronic, INC. | $137.00 | 2021-2024 | Minimed 780g |
| Dexcom, INC. | $133.49 | 2022-2025 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $126.01 | 2021-2023 | Tirosint, Licart |
| W. L. Gore & Associates, INC. | $124.75 | 2020 | |
| Abbott Laboratories | $120.18 | 2021-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $116.05 | 2023-2025 | Tymlos |
| Genzyme Corporation | $115.27 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $109.75 | 2023-2024 | Dupixent |
| Madrigal Pharmaceuticals | $106.71 | 2024-2025 | Rezdiffra, Resmetirom |
| Amarin Pharma, INC. | $103.17 | 2020-2021 | |
| Vivus LLC | $88.52 | 2020-2024 | Qsymia |
| Alexion Pharmaceuticals, INC. | $82.69 | 2022-2025 | Strensiq |
| Baxter Healthcare | $68.11 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $65.29 | 2025 | Ohtuvayre |
| Vifor Pharma, INC. | $64.79 | 2024-2025 | Zemaira |
| Kyowa Kirin, INC. | $56.02 | 2025 | |
| Kvk-Tech, INC. | $49.08 | 2024 | |
| Clarus Therapeutics INC. | $47.92 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $40.49 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $35.68 | 2025 | |
| Ani Pharmaceuticals, INC. | $32.61 | 2024 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $31.51 | 2021 | |
| Exact Sciences Corporation | $27.62 | 2023 | Cologuard Collection Kit |
| Avvisto Therapeutics, LLC | $24.49 | 2025 | Cycloset |
| Eisai INC. | $24.49 | 2022 | |
| Almatica Pharma LLC | $22.70 | 2025 | Teriparatide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.00 | 2024 | Cycloset |
| Pfizer INC. | $19.96 | 2023 | |
| Eusa Pharma (US) LLC | $18.83 | 2022 | |
| Medtronic Minimed, INC. | $17.96 | 2020 | |
| Grifols USA, LLC | $17.50 | 2023 | Prolastin-C Liquid |
| Halozyme INC | $16.64 | 2023 | |
| Axsome Therapeutics, INC. | $15.84 | 2023 | Sunosi |
| Vistapharm, INC. | $13.53 | 2021 | |
| Amryt Pharma Holdings LTD | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.